2.2.0.25truefalse40206 - Disclosure - ALLIANCES AND COLLABORATIONS (Gilead) (Details)truefalseIn Millionsfalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)
USD ($) / shares
$Duration_10_1_2010_To_12_31_2010http://www.sec.gov/CIK0000014272duration2010-10-01T00:00:002010-12-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2falsefalseUSDfalsefalse7/1/2010 - 9/30/2010
USD ($)
USD ($) / shares
$Duration_7_1_2010_To_9_30_2010http://www.sec.gov/CIK0000014272duration2010-07-01T00:00:002010-09-30T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$3falsefalseUSDfalsefalse4/1/2010 - 6/30/2010
USD ($)
USD ($) / shares
$Duration_4_1_2010_To_6_30_2010http://www.sec.gov/CIK0000014272duration2010-04-01T00:00:002010-06-30T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$4falsefalseUSDfalsefalse1/1/2010 - 3/31/2010
USD ($) / shares
USD ($)
$Duration_1_1_2010_To_3_31_2010http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-03-31T00:00:00Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5falsefalseUSDfalsefalse10/1/2009 - 12/31/2009
USD ($)
USD ($) / shares
$Duration_10_1_2009_To_12_31_2009http://www.sec.gov/CIK0000014272duration2009-10-01T00:00:002009-12-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$6falsefalseUSDfalsefalse7/1/2009 - 9/30/2009
USD ($)
USD ($) / shares
$Duration_7_1_2009_To_9_30_2009http://www.sec.gov/CIK0000014272duration2009-07-01T00:00:002009-09-30T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$7falsefalseUSDfalsefalse4/1/2009 - 6/30/2009
USD ($)
USD ($) / shares
$Duration_4_1_2009_To_6_30_2009http://www.sec.gov/CIK0000014272duration2009-04-01T00:00:002009-06-30T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$8falsefalseUSDfalsefalse1/1/2009 - 3/31/2009
USD ($)
USD ($) / shares
$Duration_1_1_2009_To_3_31_2009http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-03-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$9falsefalseUSDfalsefalse1/1/2010 - 12/31/2010
USD ($)
USD ($) / shares
$Duration_1_1_2010_To_12_31_2010http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0Unit12Divide<
MeasureSchema>http://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit15Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$10falsefalseUSDfalsefalse1/1/2009 - 12/31/2009
USD ($)
USD ($) / shares
$Duration_1_1_2009_To_12_31_2009http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit15Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$11falsefalseUSDfalsefalse1/1/2008 - 12/31/2008
USD ($)
USD ($) / shares
$Duration_1_1_2008_To_12_31_20083http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit15Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse51110000005111falsetruefalsefalsefalse2truefalsefalse47980000004798falsetruefalsefalsefalse3truefalsefalse47680000004768falsetruefalsefalsefalse4truefalsefalse48070000004807falsetruefalsefalsefalse5truefalsefalse50330000005033falsetruefalsefalsefalse6truefalsefalse47880000004788falsetruefalsefalsefalse7truefalsefalse46650000004665falsetruefalsefalsefalse8truefalsefalse43220000004322falsetruefalsefalsefalse9truefalsefalse1948400000019484falsetruefalsefalsefalse10truefalsefalse1880800000018808falsetruefalsefalsefalse11truefalsefalse1771500000017715falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 1
-Article 5
falsefalse3false0us-gaap_IncomeLossFromEquityMethodInvestmentsus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse
313000000313falsefalsefalsefalsefalse10truefalsefalse550000000550falsefalsefalsefalsefalse11truefalsefalse617000000617falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amorti
ze, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 19
-Subparagraph c
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 11
-Article 7
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 95
-Paragraph 28
Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 9
-Article 5
Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 6
-Subparagraph b
falsefalse4false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.bms.com/taxonomy/role/disclosurealliancesandcollaborationsgileaddetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsef
alsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalse<
/IsRatio>false00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalse<
DisplayZeroAsNone>false00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse12falsefalseUSDtruefalse{invest_InvestmentAxis} : Bulk Efavirenz Component of ATRIPLA* [Member]
{us-gaap_BusinessAcquisitionAxis} : Gilead [Member]
1/1/2010 - 12/31/2010
USD ($)
$Duration_1_1_2010_To_12_31_201022100http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseBulk Efavirenz Component of ATRIPLA* [Member]invest_InvestmentAxisxbrldihttp://xbrl.org/2006/xbrldibmy_BulkEfavirenzComponentOfAtriplaMemberinvest_InvestmentAxisexplicitMemberfalsefalseGilead [Member]
us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldibmy_GileadMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$13falsefalseUSD<
FootnoteIndexer />truefalse{invest_InvestmentAxis} : Bulk Efavirenz Component of ATRIPLA* [Member]
{us-gaap_BusinessAcquisitionAxis} : Gilead [Member]
1/1/2009 - 12/31/2009
USD ($)
$Duration_1_1_2009_To_12_31_20092279http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseBulk Efavirenz Component of ATRIPLA* [Member]invest_InvestmentAxisxbrldihttp://xbrl.org/2006/xbrldibmy_BulkEfavirenzComponentOfAtriplaMemberinvest_InvestmentAxisexplicitMemberfalsefalseGilead [Member]u
s-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldibmy_GileadMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$14falsefalseUSDtruefalse{invest_InvestmentAxis} : Bulk Efavirenz Component of ATRIPLA* [Member]
{us-gaap_BusinessAcquisitionAxis} : Gilead [Member]
1/1/2008 - 12/31/2008
USD ($)
$Duration_1_1_2008_To_12_31_20083210http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseBulk Efavirenz Component of ATRIPLA* [Member]invest_InvestmentAxisxbrldihttp://xbrl.org/2006/xbrldibmy_BulkEfavirenzComponentOfAtriplaMemberinvest_InvestmentAxisexplicitMemberfalsefalseGilead [Member]u
s-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldibmy_GileadMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition
available.No authoritative reference available.falsefalse5false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabe
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:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 1
-Article 5
falsefalse6false0us-gaap_IncomeLossFromEquityMethodInvestmentsus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse
-12000000-12falsetruefalsefalsefalse10truefalsefalse-10000000-10falsetruefalsefalsefalse11truefalsefalse-9000000-9falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, i
f appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 19
-Subparagraph c
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 11
-Article 7
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 95
-Paragraph 28
Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 9
-Article 5
Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 6
-Subparagraph b
falsefalse115ALLIANCES AND COLLABORATIONS (Gilead) (Details) (USD $)MillionsUnKnownUnKnownUnKnownfalsetrue
